These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies. Vici P; Pizzuti L; Mariani L; Zampa G; Santini D; Di Lauro L; Gamucci T; Natoli C; Marchetti P; Barba M; Maugeri-Saccà M; Sergi D; Tomao F; Vizza E; Di Filippo S; Paolini F; Curzio G; Corrado G; Michelotti A; Sanguineti G; Giordano A; De Maria R; Venuti A Expert Rev Vaccines; 2016 Oct; 15(10):1327-36. PubMed ID: 27063030 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects. Vonsky MS; Runov AL; Gordeychuk IV; Isaguliants MG Biochemistry (Mosc); 2019 Jul; 84(7):800-816. PubMed ID: 31509730 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccines for the prevention and treatment of cervical cancer. Tomson TT; Roden RB; Wu TC Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. Lee SJ; Yang A; Wu TC; Hung CF J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199 [TBL] [Abstract][Full Text] [Related]
13. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape. Conesa-Zamora P Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression. Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305 [TBL] [Abstract][Full Text] [Related]
15. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers. Zhang L; Zhou F; Zhao KN Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116 [TBL] [Abstract][Full Text] [Related]
16. HPV vaccines. Stanley M Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772 [TBL] [Abstract][Full Text] [Related]
17. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [TBL] [Abstract][Full Text] [Related]
18. DNA vaccines for cervical cancer: from bench to bedside. Hung CF; Monie A; Alvarez RD; Wu TC Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838 [TBL] [Abstract][Full Text] [Related]